Reference is made to the announcement by Aqua Bio Technology ASA on 12 February 2026 concerning the successful placement of the conditional private placement (the "Private Placement") with total gross proceeds of NOK 10 million, and a contemplated subsequent offering (the "Subsequent Offering").

Key information for the Subsequent Offering is set out below:

Date on which the terms of the Subsequent Offering was announced: 12 February 2026

Last day including right: 12 February 2026

First day excluding right: 13 February 2026

Record date: 16 February 2026

Maximum number of new shares: 800,000

Subscription price: NOK 5.00

Shall the rights be listed: No

The issuance of new shares in the Subsequent Offering (the "Offer Shares") will be subject to grant of a board authorization to increase the share capital, as well as completion of the Private Placement, and the Company reserves the right in its sole discretion to not conduct or cancel the Subsequent Offering.

This information is published in accordance with the requirements of the Continuing Obligations in Euronext Rule Book II.

Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA

Phone: +47 9509 2322
Email: kf@aquabiotech.no

About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-02-12 23:56 CET.

Attachments
Aqua Bio Technology ASA: Key information relating to the Subsequent Offering

Läs mer på MFN